Parents of boy with rare eye condition hail ‘amazing' results of gene therapy
Jace, from Connecticut, USA, was diagnosed with leber congenital amaurosis type 4 (LCA4) – a rare inherited eye disease that causes blindness – when he was just a baby.
He was selected for the pioneering gene therapy after his parents had a 'chance encounter' with the UK specialist involved in the trial.
His parents Brendan and DJ, who did not wish to share their surname, said the results have been 'pretty amazing'.
Jace, now six, was one of four children selected to have the treatment by specialists from Moorfields Eye Hospital and UCL Institute of Ophthalmology.
Doctors performed keyhole surgery and injected healthy copies of the affected gene into the retina, the light-sensitive layer of tissue at the back of the eye.
Three to four years on, vision in the treated eyes has 'improved substantially', according to findings now published in The Lancet.
Jace's mum DJ, 35, told the PA news agency: 'Pre-surgery, at around two years old, you could have held up any object, even a couple of inches away from Jace's face, and he would not be able to track it.
'It didn't matter how bright it was, what colour it was, what shape it was.
'And now we get calls and notes home from school that he's stealing phones out of teachers' back pockets, which is hysterical to us.
'Probably not the best thing to be happening in school, but it just goes to show how much growth he's had in his visual abilities over the past four years.
'And that's unheard of with LCA4 – you don't progress to having more vision naturally.
'It's a progression of losing it before the age of four years old. So it's amazing to watch him.'
Dad Brendan, 36, added: 'He's picking up small things off the floor. He's calling out toys.
'He's doing things that are really driven by his sight, that never would have, in our opinion, had been done before or would have been done.
'We can hold up our phone, for example, and he'll tell us, this is our phone from a good distance away. Or hold up a toy, and he can tell us what toy it is.
'If he drops something when he's eating, even if it's the smallest thing, like a Cheerio, or a gummy bear, or whatever it may be, he's able to find it on the tile or on the carpet and pick it up.
'We try to get him to not eat it, but he picks it up, I guess that's a treat for him if he can find it. It's fine with us. It's pretty amazing.'
DJ added that the family feels 'lucky' to have been given the opportunity for treatment.
'There's such a need to amplify how this treatment has been working because we think about all the other parents that are sitting there with their five-month-old scared out of their mind about what their future is going to look like,' she said.
'We were so lucky to have been able to have this option available to us and to Jace.
'No parent wants to not do as much as humanly possible for their child.
'So yes, it's giving the gift of sight to these children, but it's also giving the ability for other parents to be able to make this decision for their child by making the treatment more mainstreamed and available to the masses.'
DJ suspected something was not right with her son when he was eight weeks old and he was not looking at her and smiling.
His eyes would dart around and roll, which the couple later found out was nystagmus, a condition that causes involuntary eye movements.
DJ said being selected for the treatment felt 'very fortuitous'.
She told PA the couple had a 'chance encounter' with Professor Michel Michaelides, a consultant retinal specialist at Moorfields Eye Hospital and professor of ophthalmology at the UCL Institute of Ophthalmology, at a conference about two months before their son was formally diagnosed with LCA4.
'We knew he had LCA, we didn't know his gene variant,' she added.
'Michel was speaking at this LCA family conference in Philadelphia, and we got his contact information on the off chance that Jace would have had a version of LCA that he and his team were researching.
'Hearing the genetic diagnosis of LCA and knowing this is the exact version that Dr Michaelides and Bainbridge and their whole team at Moorfields were researching, there was almost an excitement in the room when his results were being read.
'We started the conversations almost immediately after getting his report, and we're in constant contact with the Moorfields team ever since.'
The family travelled to London in September 2020, during the Covid-19 pandemic, and quarantined for two weeks in hospital housing.
'Jace's surgery was the last day in September of 2020,' DJ said. 'He went in happy as a clam, the staff was amazing in keeping him well rested and entertained, and Brendan and myself too.
'The surgery was pretty quick. He was only under for about an hour. He has four little, kind of, I won't even call them scars, just really like pinpoints, in his eye from where they actually injected the gene therapy.
'And he came out of surgery dancing, singing, making all the nursing staff laugh. He was happy to be eating afterwards and back in our arms.
'His recovery, other than having to tolerate an eye patch for a couple of days and some drops that he didn't really like, it was pretty easy.'
Brendan said he noticed a difference within the first month when his son reacted to the sun shining through a window.
'He kind of pulled himself back,' he said. 'It wasn't just even an eye shut, it was more of a physical reaction.
'And I remember welling up and getting really emotional because that was the first time that Jace ever had any reaction to any sort of light stimulus or anything of the sort.
'From there, it's been pretty amazing.'
It is not yet known if the gene therapy will have a permanent impact on Jace's vision.
DJ said: 'We've been prepped that at some point nature kind of takes over the way that nature intended.
'I think we don't expect this to be the treatment that gets him through the rest of his life, there's always going to be changes likely in his vision, but at a certain point, too technology is getting better every single day.
'Just being able to have more children treated through this genetic therapy is going to help to give more context to what's happening within the LCA4 community.
'And our hope is that this treatment becomes more mainstreamed, and maybe if he does start to lose his vision down the road if he has a retina that's still intact, maybe there is the option for retreatment down the road.
'But this first step was huge in being able to make that a reality.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
3 hours ago
- Daily Mail
How our 'killer' immune cells can be harnessed to beat diabetes and arthritis
A 'game changing' new technique which wipes out rogue cells responsible for autoimmune conditions may offer the hope of a one-off treatment for many debilitating diseases. Around four million people in the UK live with an autoimmune condition, according to a major study published in The Lancet. These arise when immune cells produce faulty antibodies that mistakenly attack the body's own tissues, triggering inflammation and tissue damage. Depending on the condition, different parts of the body are affected. In rheumatoid arthritis, for example, it's mainly the joints, with type 1 diabetes it is cells in the pancreas that produce insulin, and in multiple sclerosis, it's the nerves, leading to numbness and movement difficulties. The new treatment harnesses the body's own immune defenders, 'natural killer' cells, to wipe out rogue white blood cells responsible for producing the antibodies that launch these attacks. Early trials show it not only improves symptoms, but 'resets' the immune system, suggesting it may offer long-lasting relief. Current treatment for autoimmune conditions often relies on long-term use of steroids and immunosuppressant drugs, but in reducing the immune response these can increase risk of infection, cancer and other complications. In the absence of effective treatments many patients face years of fatigue, pain and disability. More recently, scientists have begun trialling CAR-T therapy, better known as a cutting-edge cancer treatment, for autoimmune diseases such as lupus – where multiple tissues and organs come under attack, including the kidneys, lungs, joints and brain. CAR-T therapy works by modifying a type of white blood cell called T cells so they recognise a marker on the cancer cell and then kill it. While promising, 'one drawback to this approach is there can be significant side-effects', says Professor Lucy Walker, chair in immune regulation at the Institute of Immunity & Transplantation, University College London. These include cytokine release syndrome, where the immune system goes into dangerous over-drive, triggering widespread inflammation, and neurological complications. 'While these may be acceptable in cancer settings, as late-stage cancer patients tend to be older, for autoimmune diseases, approaches with fewer side-effects are needed because they're chronic but not immediately life-threatening and often affect younger people,' she adds. It's hoped the latest breakthrough (called CAR NK –which stands for Chimeric Antigen Receptor Natural Killer cells) may prove an even better option. The CAR NK cells are a type of immune cell genetically engineered in the lab to target the cells that produce the faulty antibodies. The immune system then regenerates with 'normal' cells. The difference with CAR-T therapy, says Professor Walker, is that with the newer technique the 'CAR' (an artificial protein that helps immune cells attack specific targets) is put in 'another type of white blood cell, the NK cell, in order to deliver the same killing effect, but with fewer toxicities'. And while CAR-T cells must be made from the patient's own immune cells in a complex and time-consuming process, CAR NK cells can be manufactured in bulk from donor umbilical cord blood or stem cells, then frozen and stored ready for use, significantly reducing cost. The treatment is already being tested on patients with lupus, a condition affecting around 70,000 people in the UK and which can be debilitating, even life-threatening. After 27 people with severe lupus received an infusion of CAR NK cell therapy, all showed signs of improvement and 70 per cent went into full remission, according to results presented in June at a major rheumatology conference in Barcelona. What's more, there were no reports of serious side-effects. In another study, published in Cell in June, researchers treated a patient with systemic sclerosis, a rare and serious autoimmune disease that attacks blood vessels and connective tissue, leading to organ damage. After treatment, the patient's skin and blood vessels began returning to normal. One benefit of using natural killer cells is they do not usually trigger rejection, so there is no need for a tissue match. Professor Zhao Dongbao, a senior immunotherapy researcher at Shanghai's Naval Medical University and one of the lead investigators on the lupus study, told Good Health CAR NK therapy 'is expected to be used for the treatment of more than ten million patients worldwide, with more than one million patients with autoimmune diseases in the US and the UK'. He says plans are under way for formal clinical trials for lupus, 'with potential expansion to other autoimmune diseases in the future'. He believes the approach could 'transform care' for people with a wide range of autoimmune conditions. But Professor Walker cautions: 'The approach is promising but is in its infancy – it's only been tested on a very small number of people.' However, she says, if follow-up work 'showed it was successful, it could represent a much more targeted approach than long-term immunosuppression and potentially be tolerated much better'. Luke Evnin, chair of the US-based Scleroderma Research Foundation, is upbeat: 'The promise is that in a single course of treatment, the patient would get lasting benefit and potentially stop other medicines and be freed from disease progression. It would be a game-changer.'
The National
3 days ago
- The National
We must get the ball rolling on how we deal with microplastics
Each week, as a result of what we drink, eat, breathe and rub up against, we ingest and absorb about five grams of plastic a week. Hilariously, that's a credit card's worth of microplastics. So you'll be glad to hear that there's a Global Plastics Treaty currently thundering to a conclusion in Geneva, this coming Thursday. It's the usual diplomatic car-crash of concerned (and unconcerned) governments, industry lobbyists and NGOs 'observing' the process. READ MORE: UK imports of Israeli fruit and veg increase as Gazans die of starvation There's a phalanx of studies gathered together in a recent paper from the leading medical journal The Lancet. It shows that pervasive micro- and nano-plastics (MNPs) in our environment are as much a health as a pollution issue. Tiny fragments of plastic suffusing our systems are disrupting pregnancies, making us stupider, shrinking male genitals, triggering inflammation that leads to cancer, cirrhosis, strokes… (Want more alarming brain news, as reported by The New York Times's David Wallace-Wells? Due to a build-up of MNPs by 50% in the past eight years, we may have the equivalent of a full plastic spoon resting in our neural tissues. This may explain a lot.) The toxic elements in plastics causing these ailments are released, as the manufactured objects degrade in our environment. Current trends (unless they change) show plastics tripling in production by 2060. This means we're laying in a 'time-bomb' of toxic sources, ready to damage our children in their future. We already have the imagery for plastics as pollutants of nature. The birds that crunch when you squeeze them, because they're so full of plastic fragments. MNPs pervade the foam of sea waves, the clouds topping Japanese mountains, the very breath of dolphins (true). Go to the deepest reaches of the ocean, and there you'll find a floating supermarket bag in the Mariana Trench. Going by all these accounts, it's not so much that we should urge the eco-crats to get it together next week – though please do, fellow humans – as that we should take a pause to wonder at our cracked and caked condition. As we are told that plastics invade both our most remote and our most intimate spaces, it's certainly hammering home the 'unthinkable harm we have done to the planet', as the Irish tech writer Mark O'Connell puts it. 'This is now being visited, in this surreal and lurid manner, on our own bodies,' he continues. 'We're having a final communion with our own garbage.' READ MORE: 'Double-edged': Gianmarco Soresi on identity, Israel, and his sold-out Fringe run O'Connell invokes Sigmund Freud's idea of repressed emotions. Because they've been pushed down, they return to us evergreen and eternal, 'unalterable by time', wreaking their bad effects on us. 'Is this not what is going on with microplastics?' he suggests. 'We can throw it away, we can fool ourselves into thinking we're 'recycling' it, but it will not absent itself. It will show up again, in the food we eat and the water we drink. 'It will haunt the milk that infants suckle from their mothers' breasts. Like a repressed memory, it remains, unalterable by time.' Wallace-Wells notes that 'whole environmental movements of the past have been built on fears of incipient contamination… But what are the lessons when pollution is seemingly everywhere, and in everyone, already?' To answer both viewpoints requires action at different scales, both personal and systemic. There are plenty of head-bending lists of how to reduce the plastic in your biological life – head-bending because it seems practically impossible to reduce it much. One Washington Post piece (from a microplastics academic expert) suggests you cut out microwaving food in plastic bowls; stop using black plastic ladles or non-stick pans; move to a plant-based diet (microplastics linger longer in large animals, so don't eat them); eschew any wrapped or processed food… You'll note the overlap between minimising your MNPs, and the diet prescriptions from the more urgent climate science reports. When the same advice comes from two different scientifically credible sources, we should maybe pay more attention. So even if you want to limit your response to self-help, the bigger systemic question inevitably arises. If it's likely that our plasticised society is incrementally disordering and disrupting us and our nature, then what kind of revolution in the conduct of our lives does that imply? For example, imagine the upheaval if we start to say: where we currently see plastic, replace them with wood, glass, clay, steel, bamboo? There's a revival and reshaping of craft production/retail implied in this response – the opposite of 'cash-to-trash' purchasing. How do we financially enable the non-affluent to join the middle classes, in surrounding themselves with non-toxic, non-throwaway, long-lasting items? How can we and our food system puncture our wobbling, consumerist complacencies, and imagine supermarkets where no single-use plastic wrapping is involved? We have to think this through, integrating several sectors. For one thing, we need more time and space, in our whole lives, so that we can relate to our consumptions in this conscious way – to shop and cook mindfully and carefully. This implicates how we deploy the AIs and automatons currently advancing upon us. Time, space and materials are required socially, so we can begin to profoundly clean up our bodies and domesticities. Artificial intelligences should be deployed to grant us those resources. What politics can start to argue for shorter working weeks, and universal basic services/incomes, as the best result of the labour-replacing machines around us? Rather than an even more broken and unhealthy society, cruelly divided between serfs and techno-monarchs? As Oscar Wilde nearly said, the problem with eco-socialism is that it takes up too many evenings. To cope with the legacy of MNPs, we'll need more days and hours reclaimed from work, replaced by forms of healing conviviality. The final news from the science is that microplastics will indeed be a legacy, rather than something we can remedy with advanced medicines. READ MORE: Labour's eviction scandal beggars belief There are no treatments in sight that will be able to remove the amount of microplastics currently in our bodies (though you can take some assurance in the news that more than 90% of MNPs we ingest are excreted). However, a percentage will linger in our tissues, organs and bones for the foreseeable future. Do we let that drive us crazy – go cartwheeling into the world of conspiracy and control, where populist characters like RFK lie in wait? Or might we actually accept our responsibilities and its consequences? The capitalist modernity we've embraced hasn't just wreaked its costs on the planet, but on ourselves and our health also. Any attempt to insulate ourselves from the climate crisis is now surely ludicrous. We can be two kinds of plastic people now. One that bears the traces, in its most intimate folds, of climate disruption. And one that can bend itself out of its conventional, defensive posture, and respond creatively to our planetary emergency. Let the former drive the latter. It seems that plasticles in your testicles needn't be a total disaster, after all.
BreakingNews.ie
3 days ago
- BreakingNews.ie
Five things that may be causing you to have back pain
Back pain often begins as a minor discomfort but can gradually become more troublesome over time, and a new study suggests that a form of talking therapy might be able to help. Published in The Lancet Rheumatology, the study explored the impact of cognitive functional therapy (CFT) – a type of psychotherapy to 'address the causal mechanisms' of chronic lower back pain and help to change the way people think about and respond to pain. Advertisement Researchers recruited more than 1,000 participants for this study and divided them into three groups: one received standard treatment, another underwent CFT, and the third received CFT along with biofeedback, which tries to teach a person to control automatic body functions. The results showed that both CFT on its own and CFT combined with biofeedback were significantly more effective than standard care in reducing activity limitation caused by lower back pain. But what actually causes back pain? Here are some of the most common causes… 1. Muscle strains and ligament sprains Sprains and strains are common causes of back pain, especially in the lower back, and can result from sudden movements, poor posture, or overuse (Alamy/PA) A common cause of back pain is an injury, like a pulled muscle. Advertisement 'The first episode of back pain is usually related to a sudden injury, ' says Sam Bhide , advanced practice physiotherapist, and founder and clinical director at Physiozen Ltd. 'Sudden movement can cause injury and bring on back pain after you return to the gym after time off, for example, because your body has forgotten what to do.' Muscle strains and ligament sprains are typically diagnosed through physical examinations which are usually conducted by physiotherapists or doctors. 'These physical examinations usually include movement, muscle and ligament tests,' says Mick Thacker, qualified physiotherapist, professor of pain at the Royal College of Surgeons in Ireland, and head of research and design 'In the majority of cases, that's actually enough to indicate potentially the best way to manage people's pain. 'This could include a variety of techniques, but usually the key aspect of managing back pain is to encourage people to stay active and do exercise which is respectful of their pain.' Advertisement 2. Osteoarthritis 'Osteoarthritis affects hyaline cartilage joints. The facet joints in your spine have hyaline cartilage, and therefore are prone to osteoarthritis,' explains Thacker. The age-related changes in the spine associated with spinal osteoarthritis is referred to as spondylosis. 'People with spondylosis generally experience a low-grade pain that follows a traditional pattern,' says Thacker. 'They tend to be very stiff for about half an hour to an hour in the morning, then it generally eases off, and they enjoy a degree of pain-free movement until the middle of the afternoon, and then their pain generally gets worse into the evening.' 3. Osteoporosis (Alamy/PA) Osteoporosis is not usually painful until a bone is broken, but broken bones in the spine are a common cause of long-term pain, according to the NHS website . Advertisement 'Osteoporosis can affect the spine and is caused by a dip in your bone mineral density,' says Thacker. 'It's often predominately seen in females, as the bone mineral density tends to drop around the menopause, and then the symptoms of osteoporosis come on about 10-15 years later, as the bone has become weaker over time. 'In terms of pain from osteoporosis, movement does benefit it, but you have to be careful. The bone is potentially fragile and weakened, so rhythmic, low intensity, but still load-bearing exercise is usually recommended.' 4. Bulging or ruptured discs (Alamy/PA) 'Discs are actually a very stable structure that don't really present that often in the clinic. However, when they do, they are generally associated with two types of problems,' says Thacker. The first issue is to do with inflammation. Advertisement 'A ruptured disc can inflame the tissue around it, and you get a small immune inflammatory episode in the surrounding tissue because discs are actually not recognised by your immune system,' explains Thacker. 'Inflammation associated with that can take several weeks to subside.' The second problem is that large disc bulges can compress the nerves in the spine, potentially affecting bowel and bladder function. 'The problem with large disc bulges is that it can actually compress the nervous tissue of the spine, and that can be quite serious if it compresses what's called your cauda equina, which is the nervous tissue at the bottom of your of spine, which can affect the nervous control to your bowel and bladder,' says Thacker. 'So, the disturbance of bowel and bladder function can be associated with back pain. That can be a medical emergency because if you don't seek care for that quickly, it can be a long-standing problem and you can become incontinent.' 5. Psychological factors (Alamy/PA) Some research suggests that there are specific risk factors associated with back pain, often referred to as 'psychosocial yellow flags'. Thacker says that factors such as stress are known to be amplifiers of a pain, rather than the generators of it. 'They're generally factors associated with people under pressure and stress at work, and under extreme workloads of work, who undergo a degree of change within the nervous system,' says Thacker. 'For example, it affects people's circulatory cortisol and stress system, and that makes people more prone to the onset of back pain. 'Also, if you've already got existing pain, factors like stress will always make that pain worse. So, unless you address those factors, people don't tend to respond well to the treatments that are advocated.' Bhide agrees and adds that combined physical and psychological treatments are particularly effective. 'In combined psychological and physical programs, people do exercises but also see a psychologist who gives their input and then talks about pain education and gives them a little bit more understanding of how to manage it better,' explains Bhide. 'This tends to be the best approach for chronic or persistent pain.'
